about
Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluentsLignocaine and indocyanine green kinetics in patients following myocardial infarction.Population pharmacokinetics of lidocaine administered during and after cardiac surgery.Investigations into distribution of lidocaine in human autopsy material.5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster.Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery.Serum concentration of lignocaine after pertubation: an observational studyFormed and preformed metabolites: facts and comparisons.A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.Pharmacokinetics of Lidocaine and Its Metabolites Following Vaginal Administration of Lidocaine Gel to Healthy Female Subjects.Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction.Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.Is Nebulized Lidocaine Adequate Topical Anesthesia for Diagnostic Transnasal Tracheoscopy?Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.The hepatic first-pass metabolism of problematic drugs.The use of lidocaine as a test of liver function in liver transplantation.The bioavailability of intranasal lignocaine.Systemic absorption of intraurethral lidocaineSaliva concentrations of lignocaine in healthy volunteers.The effect of intravenous lidocaine on laryngeal and respiratory reflex responses in anaesthetised children*.Non-invasive assessment of the haemodynamic and electrophysiological effects of medigoxin [proceedings]Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.Studies on the distribution of lidocaine in tissue after spinal and intravenous application in rabbits: clinical and forensic toxicological aspects.Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.A High-Performance Liquid Chromatography Assay Method for the Determination of Lidocaine in Human Serum.Mexiletine for thalamic pain syndrome.A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits.Reduced systemic absorption of intrabronchial lidocaine by high-frequency nebulization.Accidental lidocaine overdosage in an infant.In-vitro metabolism of lignocaine to its N-oxide.Dose-independent pharmacokinetics of intravenous lidocaine in humans.Pharmacokinetic principles of lidocaine dosing in relation to disease state.Patient pain during intravitreal injections under topical anesthesia: a systematic review.
P2860
Q28366172-882D97DB-470D-4FED-85B2-6417BEB73B41Q34519147-8FFB5036-E278-4990-84EC-EE169058A095Q35464790-7EC56659-A22B-4C02-8699-FA3E34E8DB87Q35548945-2A1B6921-F3FB-4F6F-AC5B-1F7FC9D6FF70Q35752545-9B73A52F-106C-4D52-B41E-57AA7A8BF9B7Q36061821-FAF82EFA-0241-4E93-A01D-7E5575F3F480Q36160742-03ABF03E-4F29-4E83-9AB9-F8317AE5A71AQ36909306-0A4A80D0-C5D1-4679-A936-2E88C92E73A5Q37032255-09AD3A8A-6444-4EA1-B65C-6F93478D9A67Q37199765-260C3FF4-7080-4994-B390-5AB8E758A38AQ37277366-C5F220B5-A7D3-42D6-B92A-1460CCBF00A3Q37299654-AF9587A6-ED23-48E8-9EE2-FEBDB721AFC0Q37631938-ECAB1B08-105F-41B6-B033-871600B15189Q37906607-1F101F85-A381-4F5E-ACC6-188BCCF46366Q38240990-592A6E29-FC1F-4FC8-AE4F-037173DE6283Q38344748-B2B8CA29-8E4F-427B-80E2-2219D47F036CQ39025692-5E80557E-0E4E-41ED-A07A-E9369E119B32Q40843463-B44A6BD7-E625-4A4C-903C-1264A4DD5103Q41623144-A8DBBBFC-B6AE-48C6-9A2B-D4C7CE538CA9Q42026424-C3F2B4C1-8AE9-4B55-919D-AE7C5C4F1C12Q42592561-B55E292A-4BA1-4544-8B3F-0F21FAAD32FDQ43241413-A7712021-5BC8-4AAF-B91A-765E400EF9A2Q44679629-D3D24849-FB8E-49F7-8AA3-DD86D204425BQ46099639-CCA3466A-D556-45B0-A14F-285F5D38D813Q46234087-67BEC429-20B0-4B2A-A2C7-AC4CAD12FFEAQ48240576-DC7B4512-404E-47FF-B814-46F6E9434F0EQ48257253-E61E7BB1-789B-4A02-AA8A-72467C5F0977Q48270350-D331F4B7-01D6-4CA2-8DAA-DF8772063BB5Q48852796-D8C1C4DE-2FCD-4041-B562-21D239AB32D2Q51492597-62FF1AAB-3ADD-4E7E-B737-DD336B499454Q51727511-42746D69-389E-4A9D-A944-7580347B389FQ51741141-139F140B-473F-4CAA-9B8A-E217BB521E42Q51811747-7B59CD97-3F14-4445-B3DF-DC5CC15FABFBQ51854434-EDE40147-6089-4494-B080-D466DA47F97AQ51868222-B6DE6E05-AB5A-4E88-97EA-6DD4F18C19C2Q53711262-E55A4C7E-0057-4C01-B502-3ECD98579ED1
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Clinical pharmacokinetics of lignocaine.
@en
Clinical pharmacokinetics of lignocaine.
@nl
type
label
Clinical pharmacokinetics of lignocaine.
@en
Clinical pharmacokinetics of lignocaine.
@nl
prefLabel
Clinical pharmacokinetics of lignocaine.
@en
Clinical pharmacokinetics of lignocaine.
@nl
P1476
Clinical pharmacokinetics of lignocaine.
@en
P2093
N L Benowitz
P304
P356
10.2165/00003088-197803030-00001
P577
1978-05-01T00:00:00Z
P6179
1047644701